Abstract：Objective To explore the influencing factors for sarcopenia among elderly male patients with type 2 diabetes (T2DM), so as to provide the basis for the early prevention and treatment of sarcopenia. Methods Male T2DM patients aged 60 and above admitted to Hangzhou First People's Hospital from January to December 2024 were selected as the study subjects. Demographic data, T2DM complications, and blood biochemical parameters were collected. Physical activity levels were assessed using the Chinese version of the International Physical Activity Questionnaire. The diagnosis of sarcopenia was made according to the diagnostic procedures and criteria established by the Asian Working Group for Sarcopenia in 2019. Factors affecting sarcopenia among elderly male patients with T2DM were analyzed using multivariable logistic regression model. Results A total of 455 elderly male patients with T2DM were surveyed, with a mean age of (71.80±9.55) years. The predominant physical activity level was moderate with 226 cases accounting for 49.67%. The disease course of T2DM was mainly from 10-<20 years, with 229 cases accounting for 50.33%. There were 140 cases of T2DM complications, accounting for 30.77%. A total of 138 cases of sarcopenia were detected, with a prevalence of 30.33%. Multivariable logistic regression analysis showed that age (OR=1.077, 95%CI: 1.003~1.156), body mass index (<18.5kg/m2, OR=11.056, 95%CI: 3.343~36.547; 18.5~<25.0 kg/m2, OR=2.633, 95%CI: 1.420~4.881), physical activity level (low, OR=2.469, 95%CI: 1.421~4.292), chronic obstructive pulmonary disease (yes, OR=1.871, 95%CI: 1.091~3.206), T2DM complications (yes, OR=3.015, 95%CI: 1.516~6.001), glycated hemoglobin (≥7%, OR=2.822, 95%CI: 1.423~5.590) and albumin (OR=0.810, 95%CI: 0.662~0.991) were factors affecting sarcopenia among elderly male patients with T2DM (P<0.05). Conclusion Advanced age, body mass index <25.0 kg/m2, low physical activity level, chronic obstructive pulmonary disease, T2DM complications, high glycated hemoglobin and low albumin are associated with a higher risk of sarcopenia in elderly male patients with T2DM.
[1] SAYER A A,CRUZ-JENTOFT A.Sarcopenia definition,diagnosis and treatment:consensus is growing[J].Age Ageing,2022,51(10):1-5. [2] 罗旺辉,魏琳,梁好,等.基于队列研究社区老年肌少症发病率及危险因素的Meta分析[J].中国骨质疏松杂志,2022,28(3):426-433. LUO W H,WEI L,LIANG H,et al.Incidence and risk factors of sarcopenia in the elderly in community:a meta-analysis based on cohort studies[J].Chin J Osteoporos,2022,28(3):426-433.(in Chinese) [3] 张燕,王海鑫,路秀文,等.肌少症的流行病学及影响因素研究[J].中国临床保健杂志,2022,25(5):583-588. ZHANG Y,WANG H X,LU X W,et al.Epidemiology and influencing factors of sarcopenia[J].Chin J Clin Healthc,2022,25(5):583-588.(in Chinese) [4] CHEN Z,LI W Y,HO M,et al.The prevalence of sarcopenia in Chinese older adults:meta-analysis and meta-regression[J].Nutrients,2021,13(5):1441-1456. [5] IZZO A,MASSIMINO E,RICCARDI G,et al.A narrative review on sarcopenia in type 2 diabetes mellitus:prevalence and associated factors[J].Nutrients,2021,13(1):183-186. [6] 王昆,曾翔,王兆兰,等.60岁及以上老年住院患者中肌少症患病情况及其危险因素的Meta分析[J].预防医学情报杂志,2024,40(6):737-745,754. WANG K,ZENG X,WANG Z L,et al.Meta-analysis prevalence and risk factors of sarcopenia in hospitalized elderly patients aged 60 years and above[J].J Prev Med Inf,2024,40(6):737-745,754.(in Chinese) [7] 《中国老年2型糖尿病防治临床指南》编写组.中国老年2型糖尿病防治临床指南(2022年版)[J].中国糖尿病杂志,2022,30(1):2-51. Compiling group of Clinical Guidelines for the Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China.Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China(2022 edition)[J].Chin J Diabetes,2022,30(1):2-51.(in Chinese) [8] 杨展,左满芳,王艳.国际体力活动问卷在2型糖尿病患者体力活动调查中的适用性分析[J].解放军护理杂志,2021,38(5):55-58. YANG Z,ZUO M F,WANG Y.Can the international physical activity questionnaire be used in surveying the physical activity of type 2 diabetes patients[J].Nurs J Chin PLA,2021,38(5):55-58.(in Chinese) [9] CHEN L K,WOO J,ASSANTACHAI P,et al.Asian Working Group for Sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307. [10] 黄小丽,胡越,王军,等.老年2型糖尿病患者合并肌少症风险列线图模型的建立与验证[J].现代预防医学,2024,51(19):3483-3488,3494 HUANG X L,HU Y,WANG J,et al.Establishment and validation of a risk nomogram model for sarcopenia in elderly patients with type 2 diabetes mellitus[J].Mod Prev Med,2024,51(19):3483-3488,3494.(in Chinese) [11] REN X Y,ZHANG X L,HE Q,et al.Prevalence of sarcopenia in Chinese community-dwelling elderly:a systematic review[J].BMC Public Health,2022,22(1):1-16. [12] 夏晓妹,王红,姬艳博,等.中国社区老年人肌肉衰减症影响因素的Meta分析[J].现代预防医学,2022,49(5):946-950,960. XIA X M,WANG H,JI Y B,et al.A Meta-analysis of the influencing factors of sarcopenia among the elderly in Chinese community[J].Mod Prev Med,2022,49(5):946-950,960.(in Chinese) [13] 陈谊,蔡文玮,王光辉,等.社区老年2型糖尿病患者发生肌少症的危险因素研究[J].中国临床保健杂志,2020,23(4):458-462. CHEN Y,CAI W W,WANG G H,et al.The influence factors of sarcopenia in the elderly patients with type 2 diabetes mellitus in the communities[J].Chin J Clin Healthc,2020,23(4):458-462.(in Chinese) [14] 敖玉培,冯旭,胡怀东.各种干预措施对肌少症患者炎症因子影响的meta分析[J].现代医药卫生,2023,39(12):2065-2069,2074. AO Y P,FENG X,HU H D.Effects of various interventions on inflammatory cytokines in patients with sarcopenia:a meta-analysis[J].J Mod Med Health,2023,39(12):2065-2069,2074.(in Chinese) [15] 谢明慧,梁冰,金国玺,等.老年2型糖尿病合并营养不良患者与肌少症高风险的影响因素分析[J].中华全科医学,2025,23(1):65-68,121. XIE M H,LIANG B,JIN G X,et al.Analysis of influencing factors of elderly malnutrition with type 2 diabetes with high risk of sarcopenia[J].Chin J Gen Pract,2025,23(1):65-68,121.(in Chinese) [16] 彭南昕,胡玲丽.肌少症与慢性阻塞性肺疾病的研究进展[J].老年医学与保健,2024,30(5):1482-1487. PENG N X,HU L L.Progress in sarcopenia and chronic obstructive pulmonary disease[J].Geriatr Health Care,2024,30(5):1482-1487.(in Chinese) [17] 张媛,韩正风,马艳.老年人群肌少症危险因素的病例对照研究[J].预防医学,2023,35(6):461-464. ZHANG Y,HAN Z F,MA Y.Risk factors of sarcopenia among the elderly:a case-control study[J].China Prev Med J,2023,35(6):461-464.(in Chinese) [18] 石敏,张娜娜,王琼,等.老年2型糖尿病患者肌肉减少症发生及其影响因素[J].中国老年学杂志,2021,41(19):4182-4185. SHI M,ZHANG N N,WANG Q,et al.Occurrence and influencing factors of sarcopenia in elderly patients with type 2 diabetes mellitus[J].Chin J Gerontol,2021,41(19):4182-4185.(in Chinese)
